Tag: Alcon
Alcon: Berenberg remains long, raises its target
(CercleFinance.com) – Berenberg raised Thursday from 88 to 90 Swiss francs its target price on Alcon stock, which it continues to recommend for purchase. From the analyst’s point of view,…
Alcon: in the green with an increase in forecasts
(CercleFinance.com) – Alcon gained nearly 1% in Zurich, the day after the ophthalmology laboratory raised its EPS and sales forecasts for the whole of 2023, on the occasion of publication…
Alcon: More optimistic than expected for 2023, the stock is climbing
(CercleFinance.com) – The Swiss ophthalmological group Alcon has unveiled first quarter results up and above expectations, which leads it to consider an annual profit at the top of its forecasts.…
Alcon: In the green after its annual results
(CercleFinance.com) – Alcon advances by more than 1% in Zurich, the day after the publication by the ophthalmology laboratory of an adjusted EPS of 2.24 dollars, up 4% in published…
Alcon: Amicable settlement of a dispute with J&J
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Alcon: Trompe l’oeil revision of annual objectives
(CercleFinance.com) – Alcon, the world leader in eye care, rose on the stock market on Wednesday after results just in line with market expectations and a downward revision of its…
Alcon: Berenberg cuts target, but stays buy
(CercleFinance.com) – Berenberg lowered its price target on Alcon on Tuesday, reduced from 90 to 86 Swiss francs, while maintaining its buy recommendation on the stock. ‘Throughout the past few…
Alcon: UBS remains long, reduces its target
(CercleFinance.com) – UBS reaffirms its ‘buy’ recommendation on Alcon with a price target lowered from 88 to 83.8 Swiss francs, a new target that harbors a potential upside of 28%…
Alcon continues to grow in the second quarter
Zurich (awp) – Eye care giant Alcon reported an acceleration in sales in the second quarter, while profitability fell slightly. The management of the Geneva-Texan group has generally confirmed its…
Alcon: an acquisition in dry eye disease in the USA
(CercleFinance.com) – Alcon announced on Monday that it had reached an agreement to acquire Eysuvis eye drops from the American Kala Pharmaceuticals. Approved by the FDA in January 2021, this…